000 | 01343 a2200385 4500 | ||
---|---|---|---|
005 | 20250511212652.0 | ||
264 | 0 | _c19911028 | |
008 | 199110s 0 0 eng d | ||
022 | _a0162-3109 | ||
024 | 7 |
_a10.1016/0162-3109(91)90025-t _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aD'Atri, S | |
245 | 0 | 0 |
_aDrug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells. _h[electronic resource] |
260 |
_bImmunopharmacology _c |
||
300 |
_a199-210 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAntigens, Neoplasm |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCytotoxicity, Immunologic |
650 | 0 | 4 | _aHLA Antigens |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKiller Cells, Lymphokine-Activated _ximmunology |
650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aTriazenes _xpharmacology |
650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
700 | 1 | _aMarini, S | |
700 | 1 | _aTentori, L | |
700 | 1 | _aTricarico, M | |
700 | 1 | _aFuggetta, M P | |
700 | 1 | _aBonmassar, E | |
773 | 0 |
_tImmunopharmacology _gvol. 21 _gno. 3 _gp. 199-210 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0162-3109(91)90025-t _zAvailable from publisher's website |
999 |
_c1923646 _d1923646 |